RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

324 hedge funds and large institutions have $9.31B invested in Royalty Pharma in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 139 increasing their positions, 106 reducing their positions, and 51 closing their positions.

Holders
324
Holders Change
-9
Holders Change %
-2.7%
% of All Funds
5.11%
Holding in Top 10
8
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-20%
% of All Funds
0.13%
New
45
Increased
139
Reduced
106
Closed
51
Calls
$21.9M
Puts
$5.29M
Net Calls
+$16.6M
Net Calls Change
-$18.1M

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$266M
2
Goldman Sachs
2
Goldman Sachs
New York
$112M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$55.5M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$34.8M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.19B

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.04B
2
Capital International Investors
2
Capital International Investors
California
$0
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$303M
4
RWJF
4
Robert Wood Johnson Foundation
New Jersey
$0
5
Renaissance Technologies
5
Renaissance Technologies
New York
$23.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of New York Mellon
26
Bank of New York Mellon
New York
$50.5M 1,643,455 -70,545 -4%
Bank of America
27
Bank of America
North Carolina
$47.5M 1,546,531 -335,879 -18%
Mitsubishi UFJ Trust & Banking
28
Mitsubishi UFJ Trust & Banking
Japan
$46.9M 1,527,232 -61,633 -4%
GA
29
General Atlantic
New York
$46.1M 1,500,000 – –
Charles Schwab
30
Charles Schwab
California
$45.4M 1,475,589 +68,052 +5%
Alyeska Investment Group
31
Alyeska Investment Group
Illinois
$43.7M 1,421,070 +782,676 +123%
Amundi
32
Amundi
France
$42.1M 1,372,320 +339,635 +33%
Swiss National Bank
33
Swiss National Bank
Switzerland
$41.8M 1,360,300 -40,100 -3%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$41.8M 1,358,304 +65,278 +5%
UBS AM
35
UBS AM
Illinois
$41.7M 1,157,000 – –
RCM
36
Rokos Capital Management
United Kingdom
$41M 1,331,813 +225,000 +20%
HA
37
Homestead Advisers
Virginia
$40.6M 1,322,040 +6,700 +0.5%
Sumitomo Mitsui Trust Group
38
Sumitomo Mitsui Trust Group
Japan
$40.1M 1,305,889 +18,059 +1%
TCM
39
TimesSquare Capital Management
New York
$38.6M 1,257,195 -10,635 -0.8%
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$36.3M 1,179,343 +750,586 +175%
Two Sigma Investments
41
Two Sigma Investments
New York
$34.8M 1,131,696 +957,412 +549%
Barclays
42
Barclays
United Kingdom
$33.9M 1,103,665 +670,204 +155%
Nuveen Asset Management
43
Nuveen Asset Management
Illinois
$32M 1,042,452 +35,919 +4%
EAM
44
Eventide Asset Management
Massachusetts
$32M 1,039,718 -9,395 -0.9%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$29.1M 947,600 +631,000 +199%
Deutsche Bank
46
Deutsche Bank
Germany
$26M 846,215 +313,151 +59%
Ensign Peak Advisors
47
Ensign Peak Advisors
Utah
$25.9M 842,540 -28,274 -3%
MAMU
48
Marathon Asset Management (UK)
United Kingdom
$24.7M 803,167 -90,025 -10%
Handelsbanken Fonder
49
Handelsbanken Fonder
Sweden
$24.3M 791,336 +85,802 +12%
Renaissance Technologies
50
Renaissance Technologies
New York
$23.7M 770,700 -530,200 -41%
1
2
3 4 5